Skip to content

PA Moves Trial - Patient Participants

Increasing Physical Activity in Rural Pennsylvanians: The PA Moves Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05227105
Enrollment
640
Registered
2022-02-07
Start date
2023-05-23
Completion date
2027-12-01
Last updated
2026-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2, Overweight or Obesity, Physical Inactivity

Brief summary

The purpose of this study is to address physical inactivity in rural populations in Pennsylvania.

Detailed description

People living in rural areas are diagnosed and die from cancer at higher rate than people living in cities. Physical activity has been shown to decrease the risk and occurrence of a variety of cancers, including bladder, breast, colon, endometrial, gastric, kidney, and prostate cancers. Being inactive can cause over 10% of breast and colon cancer cases. Compared to people living in cities, people living in rural areas tend to be less physically active. They're also more likely to be overweight/obese or have diabetes. Adults who are overweight, obese, or diabetic often have changes in the way their bodies deal with insulin, glucose metabolism, and inflammation. Physical activity is thought to reduce the risk of cancer by improving these issues over time. Primary care providers and their staff can identify a patient's need for more physical activity, but may not have the time or resources to give advice or assistance. We have set up a telephone-based physical activity coaching program, called the MoveLine, to give inactive patients advice and assistance in becoming more physically active. The purpose of this study is to determine if referring inactive patients to the MoveLine will help them to be more physically active over time. Approximately 880 people will take part in this research in rural areas of Pennsylvania.

Interventions

BEHAVIORALPhysical Activity

Physical activity will be encouraged up to an amount of 150 minutes per week.

Physical activity will be encouraged at the end of the trial.

Sponsors

University of Pittsburgh
Lead SponsorOTHER
National Cancer Institute (NCI)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Adults aged 18 - 75 at the time of enrollment * Either overweight/obese (Body Mass Index (BMI) ≥ 25) or diabetic (hemoglobin A1c ≥ 5.7%) * Physically inactive (defined as \< 90 min/week of self-reported structured physical activity) * Able to speak, read, and understand the English language * Resides in a rural area of Pennsylvania with a Rural Urban Continuum Code (RUCC) 4 - 9 or Rural-Urban Commuting Area (RUCA) code 4 - 10 * Must be able to provide and understand informed consent * Primary care patient of one of the participating providers * Self-report ability to walk ¼ mile * Access to a telephone

Exclusion criteria

* Cardiac

Design outcomes

Primary

MeasureTime frameDescription
Physical Activity Questionnaire12 months vs. baselineThe 11-question Morgenstern Physical Activity Questionnaire (PAQ-M) is a self-report of physical activity resulting from recreational activities, exercises, home or work activities, and chores.
Objective accelerometry12 months vs. baselineAn accelerometer will be worn for one week to track physical activity.

Secondary

MeasureTime frameDescription
Physical Activity Questionnaire24 months vs. baseline; 24 months vs. 12 monthsThe 11-question Morgenstern Physical Activity Questionnaire (PAQ-M) is a self-report of physical activity resulting from recreational activities, exercises, home or work activities, and chores.
Objective accelerometry24 months vs. baseline; 24 months vs. 12 monthsAn accelerometer will be worn for one week to track physical activity.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORKathryn Schmitz, PhD

University of Pittsburgh

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 19, 2026